tetryzoline Report issue

Small molecule Approved FDA
AACT ChEMBL DrugBank Drug Central Drugs@FDA KEGG MeSH PubChem repoDB

Active Ingredient History

NOW
  • Now
Tetrahydrozoline is an alpha adrenergic receptor agonist, which is used in form of nasal solution or spray (Tyzin) for decongestion of nasal and nasopharyngeal mucosa.   NCATS

Chemistry

More Chemistry

Pharmacology

Drug Pricing (per unit)

United States

$0.1087 - $10.8730
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

Alternative names

2-(1,2,3,4-tetrahydro-1-naphthyl)-2-imidazoline | berberil n | caltheon | collyrium fresh | diabenyl t | dl-tetrahydrozoline | eye-sine | eye-zine | murine plus | murine sore eyes | ocuzolin | ophtalmin | optazine fresh | optigene | rhinopront | (rs)-2-(1,2,3,4-tetrahydronaphthalen-1-yl)-4,5-dihydro-1h-imidazole | tetraclear | tetrahydrozeline hcl | tetrahydrozeline hydrochloride | tetrahydrozeline nitrate | tetrahydrozoline | (+/-)-tetrahydrozoline | tetrahydrozoline hcl | tetrahydrozoline hydrochloride | tetrahydrozoline, (-)-isomer | tetrahydrozoline, (+-)-isomer | tetrahydrozoline monohydrochloride | tetrahydrozoline nitrate | tetra-ide | tetrilin | tetrizolina | tetryzolin | tetryzoline | tétryzoline | tetryzoline hcl | tetryzolinum | tyzine | vasopos | visine | visine l.r. | vispring | yxin

Organizations (7)

Research & Development (5)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (2)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (6)

Approved Indications (1)


 

Nasal Obstruction (approved 1979)

Experimental Indications - Clinical Trial Phases 1-4 (5)


 

Dry Eye Syndromes (Phase 4)

Inflammation (Phase 3)

Ophthalmic Solutions (Phase 3)

Ophthalmology (Phase 4)

Pterygium (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial Organizations: 5

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue